Look for New GLP-1 Agonists for Type 2 Diabetes

You'll see Adlyxine (ad-LIKS-een, lixisenatide) and Ozempic (oh-ZEM-pik, semaglutide) join the crowded field of GLP-1 agonists.

Adlyxine is available now...and Ozempic will be in March. This will bring the tally in Canada to six GLP-1 agonist products for diabetes.

Be familiar with how the different agents compare.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote